ArticleSignal transduction and targeted therapy

TGIF2 promotes the progression of lung adenocarcinoma by bridging EGFR/RAS/ERK signaling to cancer cell stemness.

Renle Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.